Indefinite Delivery Contract 36C24526D0059
- Not listed
- The Department of Veterans Affairs Veterans Integrated Service Network 10 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on May 1, 2026, for hazardous pharmaceutical compounding services, with a ceiling of $7,570,831.40 and an ultimate completion date of April 30, 2027. This is a single-award, no-set-aside contract. Optum Infusion Services 308, LLC will perform work at multiple VA Medical Centers across Indiana, Ohio, and Michigan, with administrative oversight at...
- Veterans Integrated Service Network 2 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on August 24, 2026, with a ceiling of $240,583.99 for compounded chemotherapy drugs, in a single-award procurement with no set-aside designation. Place of performance is Chandler, Arizona. The contract stems from a sole-source solicitation (36C24226Q0550) issued April 20, 2026, to procure ready-to-administer, patient-specific chemotherapy drugs prepared under FDA 503A compliance, VHA...
- Veterans Integrated Service Network 2 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on September 1, 2026, with a ceiling value of $117,000.00 for chemotherapy compounding services at the Toms River VA facility through August 31, 2027. This is a single-award contract with no set-aside designation. Place of performance is Chandler, Arizona. The contract supports FDA 503A-compliant pharmaceutical compounding and hazardous chemotherapy preparation services, requiring...
- Veterans Integrated Service Network 22 awarded a single-award indefinite-delivery contract to Optum Pharmacy 801, Inc. for $2,012,758.65 on October 1, 2024, to supply compounded chemotherapy medications. The contract has no set-aside designation and runs through September 30, 2026. Place of performance is Phoenix, Arizona. The originating solicitation sought supply and delivery of over 350 listed compounded chemotherapy products to the VA Long Beach Healthcare System, with a base period from...
- Veterans Integrated Service Network 17 awarded a single-award indefinite-delivery contract to Optum Infusion Services 308, LLC for pharmacy compounding services focused on oncology drugs at the Dallas VA Healthcare System, with a contract ceiling of $6 million and an award date of November 1, 2025. The contract runs from November 1, 2025, through October 31, 2030. Performance occurs at the Dallas VA Medical Center (4500 S Lancaster Road, Dallas, Texas 75216) and the Garland VA Clinic, with...
- Veterans Integrated Service Network 17 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC, with a $500,000 ceiling on November 1, 2025, for Amarillo VA pharmacy compounding of oncology medications. This is a single-award contract without set-aside designation. Performance occurs at the Amarillo VA Healthcare System Pharmacy Services, 6010 W Amarillo Blvd, Amarillo, Texas 79106. The originating solicitation 36C25725Q0759, posted July 29, 2025, and due August 28, 2025,...
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, holds a single-award Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs Veterans Integrated Service Network 2 (VISN 2) for the provision of chemotherapy compound chemical mixes. The agreement, valued at $500,000, was awarded on August 24, 2021, with an ultimate completion date of August 23, 2026. The contract employs a firm fixed-price pricing structure with no set-aside designation,...
- Veterans Integrated Service Network 15 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on September 1, 2026, with a ceiling of $357,644.88 and ultimate completion date of August 31, 2031. This is a single-award, unrestricted contract. The originating solicitation, posted January 13, 2026, requested compounded sterile pharmaceutical preparations and associated supplies for VISN 15 facilities, including hazardous and non-hazardous compounded intravenous products,...
- This indefinite delivery contract was awarded by the Veterans Integrated Service Network 2, a civilian federal agency, to Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract has a ceiling value of $1,071,930.52 and a period of performance from October 1, 2025 to September 30, 2026. The contract is for chemo compounding services, with a single task order for $1,071,930.52 to provide these services. The place of performance is Chandler, Arizona. No...
- The Department of Veterans Affairs' Veterans Integrated Service Network 20 awarded an indefinite-delivery contract to Optum Pharmacy 801, Inc. for pharmacy hazardous compounding services with a ceiling of $20,000.00 and an award date of October 1, 2025. This is a single-award IDIQ with no set-aside designation, with performance extending through September 30, 2030. No specific place of performance is identified in the contract record beyond the contractor's established operations. The...
- 36C24526D0059Indefinite Delivery Contract
- 1Federal Contract Awards
Veterans Integrated Service Network 5 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on August 27, 2026, for contingency chemotherapy compounding services, with a ceiling of $300,000 and ultimate completion date of August 26, 2031. This is a single-award contract issued without set-aside designation under firm fixed-price terms. Performance takes place at the Louis A. Johnson VA Medical Center, Clarksburg, West Virginia, with contingency compounding capability maintained at Chandler, Arizona. The contractor provides on-demand aseptic compounding of patient-specific chemotherapy orders, including chemotherapy agents, closed-system drug transfer devices, IV tubing, bags, and ancillary supplies, delivered patient-ready prior to scheduled infusion dates. All work must comply with FDA 503A standards and USP 797 and USP 800 requirements. The base performance period runs August 27, 2026 through August 26, 2027, with four one-year option periods. The contract ceiling is approximately $349,000, with a minimum guaranteed amount of $300. Billing is based on actual billable units of medication used per patient, with separate line items for compounding labor, drugs, supplies, and shipping. Evaluation uses Lowest Price Technically Acceptable methodology. The NAICS code is 621610 (Medical Laboratories); PSC is Q517 (Pharmacy Services). A delivery order for $60,000 in contingency chemotherapy compounding services was issued under this IDIQ on August 27, 2026, with ultimate completion August 26, 2027, for performance at Chandler, Arizona.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 8/24/26 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C24526D0059-36C24526N0831 | Optum Infusion Services 308, LLC | $60.0k | 8/27/26 | 8/26/27 | 8/24/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q517--Contingency Chemotherapy Compounding Services for the Louis A. Johnson VA Medical Center | 36C24526Q0652 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 | Solicitation 1/1 | 7/30/26, 5:15 PM |